On Monday, I recapped our latest Big Apple biotech event, “New York’s Life Science Disruptors.” Today I’ve come back with the slideshow look at the action.
In case you missed it, the event was a candid series of chats with key figures in different spectrums of New York biotech—startups, academics, established companies, and investors.
As you can see from the slideshow, the packed house was full of smiles—thanks again to all of our attendees, speakers, and moderators for a great time. Great thanks as well to our event host, Alexandria Real Estate Equities, and our sponsors: Eisner Amper, Halloran Consulting Group, and Kenyon. And thanks as well to Keith Spiro of Keith Spiro Photography for the photos (and to the weather for holding up). We’ll see you all again next year.
Author: Ben Fidler
Ben is former Xconomy Deputy Editor, Biotechnology. He is a seasoned business journalist that comes to Xconomy after a nine-year stint at The Deal, where he covered corporate transactions in industries ranging from biotech to auto parts and gaming. Most recently, Ben was The Deal’s senior healthcare writer, focusing on acquisitions, venture financings, IPOs, partnerships and industry trends in the pharmaceutical, biotech, diagnostics and med tech spaces. Ben wrote features on creative biotech financing models, analyses of middle market and large cap buyouts, spin-offs and restructurings, and enterprise pieces on legal issues such as pay-for-delay agreements and the Affordable Care Act. Before switching to the healthcare beat, Ben was The Deal's senior bankruptcy reporter, covering the restructurings of the Texas Rangers, Phoenix Coyotes, GM, Delphi, Trump Entertainment Resorts and Blockbuster, among others. Ben has a bachelor’s degree in English from Binghamton University.
View all posts by Ben Fidler
